Allarity Therapeutics Inc (ALLR)

Jan 20, 2025

No Stopping Allarity Therapeutics Inc (NASDAQ: ALLR)’s Stock Surged? - Stocks Register

Jan 20, 2025

Jan 19, 2025

2025-01-19 | Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ALLR | Press Release - Stockhouse Publishing

Jan 19, 2025

Jan 15, 2025

2025-01-15 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Reach Out | NDAQ:ALLR | Press Release - Stockhouse Publishing

Jan 15, 2025

Jan 12, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Connect - AccessWire

Jan 12, 2025

Jan 09, 2025

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus.com

Jan 09, 2025

Jan 09, 2025

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire

Jan 09, 2025

Jan 08, 2025

2025-01-08 | Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | NDAQ:ALLR | Press Release - Stockhouse Publishing

Jan 08, 2025

Jan 05, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Stockholders to Learn More About the Investigation - AccessWire

Jan 05, 2025

Jan 02, 2025

2025-01-02 | Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ALLR | Press Release - Stockhouse Publishing

Jan 02, 2025

Jan 02, 2025

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire

Jan 02, 2025

Dec 30, 2024

2024-12-30 | Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Investors to Inquire about Securities Investigation | NDAQ:ALLR | Press Release - Stockhouse Publishing

Dec 30, 2024

Dec 20, 2024

ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - The Eastern Progress Online

Dec 20, 2024

Dec 18, 2024

ALLARITY THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

Dec 18, 2024

Dec 18, 2024

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities laws - The Eastern Progress Online

Dec 18, 2024

Dec 16, 2024

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit - Kilgore News Herald

Dec 16, 2024

Dec 16, 2024

ALLR Deadline: ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit - The Eastern Progress Online

Dec 16, 2024

Dec 11, 2024

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online

Dec 11, 2024

Dec 10, 2024

Allarity Therapeutics stock hits 52-week low at $1.03 - Investing.com

Dec 10, 2024

Dec 10, 2024

Allarity Therapeutics stock hits 52-week low at $1.03 By Investing.com - Investing.com UK

Dec 10, 2024

Dec 08, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allarity Therapeutics, Inc. Inc. of Class Action Lawsuit and Upcoming DeadlinesALLR - Longview News-Journal

Dec 08, 2024

Dec 06, 2024

Allarity Therapeutics, Inc. Investors: Please contact the - GlobeNewswire

Dec 06, 2024

Dec 06, 2024

Allarity Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 12, 2024 Deadline to file Lead Plaintiff Motion - GlobeNewswire Inc.

Dec 06, 2024

Nov 28, 2024

Allarity Therapeutics stock hits 52-week low at $1.14 By Investing.com - Investing.com South Africa

Nov 28, 2024

Nov 27, 2024

Allarity Therapeutics stock hits 52-week low at $1.14 - Investing.com

Nov 27, 2024

Nov 23, 2024

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, I - GuruFocus.com

Nov 23, 2024

Nov 23, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates - GuruFocus.com

Nov 23, 2024

Nov 18, 2024

Allarity Therapeutics stock hits 52-week low at $1.25 By Investing.com - Investing.com Canada

Nov 18, 2024

Nov 18, 2024

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements - GlobeNewswire

Nov 18, 2024

Nov 18, 2024

Allarity's Phase 2 Cancer Drug Shows Promise: Patients Exceed 14-Month Treatment | ALLR Stock News - StockTitan

Nov 18, 2024

Nov 14, 2024

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights - The Manila Times

Nov 14, 2024

Nov 14, 2024

Allarity Therapeutics Reports $18.5M Cash Position, Extended Runway in Q3 Results | ALLR Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

FINAL REMINDER ALLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Allarity Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit! - AccessWire

Nov 13, 2024

Nov 12, 2024

DEADLINE ALERT for ALLR, and COIN: The Law Offices of Frank - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - Business Wire

Nov 12, 2024

Nov 11, 2024

FINAL ALLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Allarity Therapeutics, Inc. Investors to Join the Class Action Lawsuit! - AccessWire

Nov 11, 2024